{
  "docId": "019de076-2ada-7117-9358-036add78e997",
  "docSlug": "d07954bb4369650f4386921d5f3a9e2d",
  "documentTitle": "Dare Bioscience | Results Presentation Deck | 14 slides",
  "authorId": "dare-bioscience",
  "authorName": "Daré Bioscience",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 14,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 13,
  "notes": "The slide uses a hub-and-spoke diagram to segment the addressable market.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-2ada-7117-9358-036add78e997/13",
  "deckHref": "/decks/019de076-2ada-7117-9358-036add78e997",
  "deckJsonHref": "/decks/019de076-2ada-7117-9358-036add78e997.json",
  "deckAnchorHref": "/decks/019de076-2ada-7117-9358-036add78e997#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.23,
        "y": 0.248
      },
      "kind": "diagram",
      "text": "35 Million Women Potential Candidates for Ovaprene",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90db2494-53d4-427a-a4c4-9725948757c6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.68,
        "y": 0.52
      },
      "kind": "list",
      "text": "Not candidates: Sterilization (10.5M), Pregnant/seeking (5.6M), Never had intercourse (8.2M), LARC (5.4M)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b033a18-9b5b-454a-b61a-d8d193fb9ecb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.6,
        "x": 0.04,
        "y": 0.39
      },
      "kind": "list",
      "text": "Current Non-Users: 12M; Current Hormone-free: 11M; Current Hormonal: 12M",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b2eb8c3-4474-4a11-a982-88b5422e0370",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.3,
        "x": 0.01,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. Market research study conducted in 2019 for Daré Bioscience 2. Contraceptive use data applied to 2019 population data from US Census",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a3b2410-1951-4906-8457-9a6446ae812c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.07,
        "y": 0.04
      },
      "kind": "title",
      "text": "Ovaprene® - Potential Market Opportunity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70f3109c-5a92-4422-9738-b2ec1ccf3c6f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "market-segmentation",
      "slug": null,
      "matchId": "8a6fc159-c3f4-41cb-9481-9a6f9bcd7a3a",
      "evidence": "Segmentation of total population into potential candidates and non-candidates based on contraceptive usage.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 13,
      "from": 12,
      "beatId": "bd7b5bbc-516b-4cc4-bf57-a08c4b318fce",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Slides 12 and 13 provide market sizing information for Contraception and Ovaprene",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 11,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "a5364aee-83ce-4e62-88bd-2a73446e65eb",
      "evidence": "The presentation emphasizes the lack of FDA-approved treatments for FSAD/FSIAD and the potential of Daré Bioscience's products",
      "position": 0,
      "objective": "Highlight the importance of Daré Bioscience's products in addressing unmet medical needs",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}